CTRI/2021/09/036462Not yet recruitingPhase 4
To Evaluate The Therapeutic Efficacy Of Intranasal Tapentadol In Pain Management In Opioid Use Disorder
GMC RH Patiala0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1.Male and female patients aged 18-65 years with ICD-10 diagnosis of Opioid Dependence.
- •2.Patients who will bw mdeically stable.
- •3.Patients who have given written informed consent.
Exclusion Criteria
- •1. History of chronic psychosis or drug induced psychosis of any kind.
- •2. Patients with paralytic ileus and respiratory depression.
- •3. Pregnant women, lactating mothers, surgically-sterile women or women who agree to continue using applicable birth control throughout the trial. All women of child-bearing potential must have a negative urine pregnancy test.
- •4. History of seizures, renal insufficiency or congestive heart failure.
- •5. History of ketamine abuse/dependence or prior clinically significant adverse reaction to ketamine.
Investigators
Similar Trials
Not yet recruiting
Phase 4
Evaluation of nasal administration of extract of Brahmi leaves (INDCA-NS) in the treatment of tension-type headacheCTRI/2020/10/028285Indus Biotech Private Limited
Recruiting
Not Applicable
Evaluation of the Use of Antiseptic Nose For Decolonization of Resistant Bacteria in HospitalsHuman patients infectedMethicillin-resistant Staphylococcus aureus.B03.300.390.400.800.750.100.500RBR-6gs2jhFaculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Not yet recruiting
Phase 2
Study of intranasal oil instillation (Pratimarsha Nasya)for protective effect in healthy individualsCTRI/2022/06/043096Central Council for Research in Ayurvedic Sciences
Not yet recruiting
Phase 3
Investigating the preventive effect of intranasal dexamethasone in reducing nausea and vomiting after laparoscopic surgery in childreIRCT20180416039326N24Esfahan University of Medical Sciences42
Recruiting
Phase 3
Topical Intranasal Tranexamic Acid in EpistaxisIRCT20210403050815N1Shiraz University of Medical Sciences240